HSBC Holdings’s ARK Genomic Revolution ETF ARKG Stock Holding History

HSBC Holdings’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,000	Closed	-$252K	–	2923
2022 Q2	$252K	Sell	8,000 -2	-0%	-$70	﹤0.01%	2737
2022 Q1	$368K	Sell	8,002 -61,709	-89%	-$2.94M	﹤0.01%	2629
2021 Q4	$4.27M	Sell	69,711 -12,690	-15%	-$877K	﹤0.01%	1334
2021 Q3	$6.16M	Sell	82,401 -105	-0.1%	-$8.81K	0.01%	1073
2021 Q2	$7.63M	Sell	82,506 -1,118	-1%	-$95.1K	0.01%	951
2021 Q1	$7.42M	Buy	83,624 +63,774	+321%	+$6.33M	0.01%	883
2020 Q4	$1.85M	Buy	19,850 +10,500	+112%	+$837K	﹤0.01%	1364
2020 Q3	$596K	Buy	+9,350	New	+$548K	﹤0.01%	1829

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

HSBC Holdings's ARKG Position: Q3 2022 in Review

HSBC Holdings sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 8,000 shares — an estimated $252K sold.

HSBC Holdings first reported a position in ARKG in Q3 2020 and held it in 8 quarters. The position peaked at $7.63M in Q2 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

HSBC Holdings reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
HSBC Holdings sold 8,000 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $252K.
HSBC Holdings first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 8 quarters.
HSBC Holdings's ARK Genomic Revolution ETF position peaked at $7.63M in Q2 2021.
311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on HSBC Holdings's 13F filing for Q3 2022, filed 14 Nov 2022.